CD1D and renal cell carcinoma: The abundance of lipid sulfatide and glycosphingolipids contributing to RCC progression [10,22,23,24,25] led us to hypothesize that these molecules present on CD1d in RCC may play an important role in activating CD3low Vγ9δ1 T cells.